874013-97-5

Usage

Uses

Used in Pharmaceutical Industry:
7-Chloro-2-Methyl-1H-pyrrolo[2,3-c]pyridine is used as a key building block for the synthesis of pharmaceutical drugs and biologically active molecules, contributing to the development of new therapeutic agents.
Used in Medicinal Chemistry Research:
7-Chloro-2-Methyl-1H-pyrrolo[2,3-c]pyridine is utilized as a research tool in medicinal chemistry, aiding in the discovery and optimization of drug candidates with potential therapeutic benefits.
Used in Drug Discovery:
7-Chloro-2-Methyl-1H-pyrrolo[2,3-c]pyridine plays a role in drug discovery processes, where it may be employed to identify novel compounds with specific pharmacological properties or to understand the mechanisms of action of existing drugs.

Upstream product

• 5470-18-8 2-Chloro-3-nitropyridine 
• 920-39-8 isopropylmagnesium bromide 
• 13154-14-8 1-propenylmagnesium bromide 
• 1415124-77-4 7-chloro-2-methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-c]pyridine 

Relevant academic research and scientific papers

Molecular modeling, design, synthesis, and biological activity of 1H-pyrrolo[2,3-c]pyridine-7-amine derivatives as potassium-competitive acid blockers

A series of 1H-pyrrolo[2,3-c]pyridine-7-amine derivatives were designed and synthesized based on our docking model as potassium-competitive acid blockers (P-CABs). Molecular modeling of these derivatives led us to introduce a substituent at the 1-position

HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS

The present invention provides a heterocyclic compound of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof or a hydrate thereof, wherein A, A′ B, D, R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) useful for treating or preventing a disease, condition or disorder associated with protein kinases, preferably Janus Kinase family.

HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS

The present invention provides a heterocyclic compound of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof or a hydrate thereof, wherein A, A' B, D, R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) useful for treating or preventing a disease, condition or disorder associated with protein kinases, preferably Janus Kinase family.

PYRROLOY2,3-c¨PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE

Provision of a compound having a superior proton pump action, which shows an antiulcer activity and the like after conversion to an in vivo proton pump inhibitor, a production method thereof and use thereof. A pyrrolo[2,3-c]pyridine compound represented by the formula: wherein each symbol is as defined in the specification.